Perceptive Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Perceptive Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,333	Closed	-$567K	–	183
2015 Q3	$567K	Hold	3,333	–	–	0.05%	108
2015 Q2	$2.11M	Hold	3,333	–	–	0.14%	100
2015 Q1	$1.72M	Buy	3,333 +952	+40%	+$480K	0.14%	88
2014 Q4	$1.27M	Buy	+2,381	New	+$1.07M	0.11%	100
2013 Q3	–	Sell	-276	Closed	-$301K	–	127
2013 Q2	$301K	Buy	+276	New	+$308K	0.03%	71

Other funds holding VIRX

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return